These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30109718)

  • 1. Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
    Leão J; Leiva V; Saulo H; Tomazella V
    Stat Med; 2018 Dec; 37(29):4421-4440. PubMed ID: 30109718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birnbaum-Saunders frailty regression models: Diagnostics and application to medical data.
    Leão J; Leiva V; Saulo H; Tomazella V
    Biom J; 2017 Mar; 59(2):291-314. PubMed ID: 28054373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On a new piecewise regression model with cure rate: Diagnostics and application to medical data.
    Gómez YM; Gallardo DI; Leão J; Calsavara VF
    Stat Med; 2021 Dec; 40(29):6723-6742. PubMed ID: 34581460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transformation class for spatio-temporal survival data with a cure fraction.
    Hurtado Rúa SM; Dey DK
    Stat Methods Med Res; 2016 Feb; 25(1):167-87. PubMed ID: 22514030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term frailty modeling using a non-proportional hazards model: Application with a melanoma dataset.
    Calsavara VF; Milani EA; Bertolli E; Tomazella V
    Stat Methods Med Res; 2020 Aug; 29(8):2100-2118. PubMed ID: 31691640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new cure rate model with flexible competing causes with applications to melanoma and transplantation data.
    Leão J; Bourguignon M; Gallardo DI; Rocha R; Tomazella V
    Stat Med; 2020 Oct; 39(24):3272-3284. PubMed ID: 32716081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cure rate models for heterogeneous competing causes.
    Brandão M; Leão J; Gallardo DI; Bourguignon M
    Stat Methods Med Res; 2023 Sep; 32(9):1823-1841. PubMed ID: 37489264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A flexible family of transformation cure rate models.
    Koutras MV; Milienos FS
    Stat Med; 2017 Jul; 36(16):2559-2575. PubMed ID: 28417477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation method of the semiparametric mixture cure gamma frailty model.
    Peng Y; Zhang J
    Stat Med; 2008 Nov; 27(25):5177-94. PubMed ID: 18613271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective 3-parameter Gompertz model with frailty term for estimating cure fraction in survival data.
    Hajizadeh N; Baghestani AR; Pourhoseingholi MA; Khadem Maboudi AA
    J Biopharm Stat; 2023 Jan; 33(1):90-113. PubMed ID: 35671330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Likelihood inference for COM-Poisson cure rate model with interval-censored data and Weibull lifetimes.
    Pal S; Balakrishnan N
    Stat Methods Med Res; 2017 Oct; 26(5):2093-2113. PubMed ID: 28656795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penalized likelihood estimation of a mixture cure Cox model with partly interval censoring-An application to thin melanoma.
    Webb A; Ma J; Lô SN
    Stat Med; 2022 Jul; 41(17):3260-3280. PubMed ID: 35474515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival models induced by zero-modified power series discrete frailty: Application with a melanoma data set.
    Molina KC; Calsavara VF; Tomazella VD; Milani EA
    Stat Methods Med Res; 2021 Aug; 30(8):1874-1889. PubMed ID: 33955295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling survival data with a cured fraction using frailty models.
    Price DL; Manatunga AK
    Stat Med; 2001 May 15-30; 20(9-10):1515-27. PubMed ID: 11343371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified score function for monotone likelihood in the semiparametric mixture cure model.
    Almeida FM; Colosimo EA; Mayrink VD
    Biom J; 2022 Mar; 64(3):635-654. PubMed ID: 34845768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of different bivariate correlated frailty models and estimation strategies.
    Wienke A; Arbeev KG; Locatelli I; Yashin AI
    Math Biosci; 2005 Nov; 198(1):1-13. PubMed ID: 16185720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint frailty model for recurrent events and death in presence of cure fraction: Application to breast cancer data.
    Talebi-Ghane E; Baghestani A; Zayeri F; Rondeau V; Akhavan A
    Biom J; 2021 Apr; 63(4):725-744. PubMed ID: 33368665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proportional hazards under Conway-Maxwell-Poisson cure rate model and associated inference.
    Balakrishnan N; Barui S; Milienos FS
    Stat Methods Med Res; 2017 Oct; 26(5):2055-2077. PubMed ID: 28523958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vertical modeling: analysis of competing risks data with a cure fraction.
    Nicolaie MA; Taylor JMG; Legrand C
    Lifetime Data Anal; 2019 Jan; 25(1):1-25. PubMed ID: 29388073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.